Erratum to ‘Efficacy and correlative analyses of avelumab plus axitinib versus sunitinib in sarcomatoid renal cell carcinoma: post hoc analysis of a randomized clinical trial’: [ESMO Open Volume 6, Issue 3, June 2021, 100101] (ESMO Open (2021) 6(3), (S2059702921000582), (10.1016/j.esmoop.2021.100101))

T. K. Choueiri, J. Larkin, S. Pal, R. J. Motzer, B. I. Rini, B. Venugopal, B. Alekseev, H. Miyake, G. Gravis, M. A. Bilen, S. Hariharan, A. Chudnovsky, K. A. Ching, X. J. Mu, M. Mariani, P. B. Robbins, B. Huang, A. di Pietro, L. Albiges

    Research output: Contribution to journalComment/debate

    Abstract

    The publisher regrets that some minor corrections to punctuation were missed in the typesetting process. In addition, Figure 3C was incorrect when the article was published. All corrections have now been applied to the article and the figure corrected. The corrected Figure 3C also appears below: [Figure presented] The publisher would like to apologise for any inconvenience caused.

    Original languageEnglish
    Article number100177
    JournalESMO Open
    Volume6
    Issue number4
    DOIs
    Publication statusPublished - 1 Aug 2021

    Cite this